{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:12:22Z","timestamp":1791821542003,"version":"4.3.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/bega.2001.0230","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"705-722","source":"Crossref","is-referenced-by-count":49,"title":["Epidemiology of NSAID-related gastroduodenal mucosal injury"],"prefix":"10.1053","volume":"15","author":[{"given":"Claus","family":"Aalykke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2001.0230_RF1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01662127","article-title":"Pharmacologisches \u00fcber Aspirin (Acetylsalicylsa\u00fcre)","volume":"76","author":"Dreser","year":"1899","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1053\/bega.2001.0230_RF2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(00)78970-7","article-title":"Gastroscopic observations of the effect of aspirin and certain other substances on the stomach","volume":"2","author":"Douthwaite","year":"1938","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature New Biology"},{"key":"10.1053\/bega.2001.0230_RF4","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF5","doi-asserted-by":"crossref","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","article-title":"The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes","volume":"265","author":"Fu","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/bega.2001.0230_RF6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF7","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(98)00274-5","article-title":"Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology","volume":"105","author":"McCarthy","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF8","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1016\/S0002-9343(97)00207-6","article-title":"Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury","volume":"104","author":"Griffin","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/00365529509093304","article-title":"Nonsteroidal antiinflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates","volume":"30","author":"Hallas","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF10","series-title":"NSAIDs: a Profile of Adverse Effects","first-page":"25","article-title":"The spectrum of adverse gastrointestinal effects associated with nonsteroidal anti-inflammatory drugs","author":"Borda","year":"1992"},{"key":"10.1053\/bega.2001.0230_RF11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0016-5085(89)80061-7","article-title":"Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use","volume":"96","author":"Fries","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(00)02826-9","article-title":"Epidemiological assessment of drug-induced disease","volume":"356","author":"Kaufman","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF13","series-title":"Modern Epidemiology","first-page":"35","article-title":"Measures of effect","author":"Rothman","year":"1986"},{"key":"10.1053\/bega.2001.0230_RF14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis recieving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial","volume":"123","author":"Silverstein","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF15","first-page":"704","article-title":"Evaluating risk: a primer for gastroenterologists","volume":"90","author":"Eisen","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-126-9-199705010-00007","article-title":"Using numerical results from systematic reviews in clinical practice","volume":"126","author":"McQuay","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF17","series-title":"Foundations of Epidemiology","first-page":"226","article-title":"Observational studies: II. Case-control studies","author":"Lilienfeld","year":"1994"},{"key":"10.1053\/bega.2001.0230_RF18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004836-199701000-00002","article-title":"Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking","volume":"24","author":"Kurata","year":"1997","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiology","volume":"160","author":"Hernandez-Diaz","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF22","first-page":"1153","article-title":"Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use","volume":"82","author":"Larkai","year":"1987","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF23","first-page":"315","article-title":"Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta","volume":"151","author":"Hogan","year":"1994","journal-title":"Canadian Medical Association Journal"},{"key":"10.1053\/bega.2001.0230_RF24","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"26","author":"Singh","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.2001.0230_RF25","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration","volume":"28","author":"Armstrong","year":"1987","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.2001.0230_RF28","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0016-5085(99)70334-3","article-title":"A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis","volume":"117","author":"Laine","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF30","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.282.20.1929","article-title":"Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs","volume":"282","author":"Langman","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.2001.0230_RF31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/jama.282.20.1961","article-title":"COX-1-sparing NSAIDs\u2013is the enthusiasm justified?","volume":"282","author":"Peterson","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.2001.0230_RF32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00042737-199306000-00004","article-title":"Non-steroidal anti-inflammatory drug-associated upper gastrointestinal ulceration and complications","volume":"5","author":"Hudson","year":"1993","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0230_RF33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01393353","article-title":"Gastric adaptation occurs with aspirin administration in man","volume":"28","author":"Graham","year":"1983","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0230_RF34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0016-5085(89)80063-0","article-title":"Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies","volume":"96","author":"McCarthy","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/gut.35.8.1030","article-title":"Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs","volume":"35","author":"Hudson","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/gut.31.9.989","article-title":"Towards a true pervalence of peptic ulcer: the Sorreisa gastrointestinal disorder study","volume":"31","author":"Bernersen","year":"1990","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-91-4-517","article-title":"Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy","volume":"91","author":"Silvoso","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF38","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1001\/archinte.1996.00440190069008","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials","volume":"156","author":"Koch","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.36.3.334","article-title":"Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori","volume":"36","author":"Taha","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archinte.1995.00430130043005","article-title":"Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study","volume":"155","author":"Lanza","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons","volume":"141","author":"Smalley","year":"1995","journal-title":"American Journal of Epidemiology"},{"key":"10.1053\/bega.2001.0230_RF42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0002-9343(91)90118-H","article-title":"Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models","volume":"91","author":"Fries","year":"1991","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.315.7119.1333","article-title":"Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study","volume":"315","author":"MacDonald","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00001648-199701000-00003","article-title":"Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation","volume":"8","author":"Gutthann","year":"1997","journal-title":"Epidemiology"},{"key":"10.1053\/bega.2001.0230_RF45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM199409153311107","article-title":"Bleeding peptic ulcer","volume":"331","author":"Laine","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.300.6720.278","article-title":"Non-steroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up","volume":"300","author":"Hawkey","year":"1990","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF48","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1992.00400180139023","article-title":"The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease","volume":"152","author":"Bollini","year":"1992","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","article-title":"Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis","volume":"312","author":"Henry","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/gast.1997.v112.pm9041228","article-title":"Evidence of aspirin use in both upper and lower gastrointestinal perforation","volume":"112","author":"Lanas","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(99)00267-5","article-title":"Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use","volume":"85","author":"Tramer","year":"2000","journal-title":"Pain"},{"key":"10.1053\/bega.2001.0230_RF52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2000.9561","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"119","author":"Hawkey","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF53","first-page":"S2","article-title":"Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum","volume":"31","author":"Langman","year":"1999","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0230_RF54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.158.1.33","article-title":"Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs","volume":"158","author":"Garcia Rodriguez","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF56","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","article-title":"The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption","volume":"94","author":"Kaufman","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF57","first-page":"1058","article-title":"Alcohol consumption and the risk of major upper gastrointestinal bleeding","volume":"90","author":"Kelly","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1047-2797(00)00040-5","article-title":"The effect of alcohol abuse on the risk of NSAID-related gastrointestinal events","volume":"10","author":"Neutel","year":"2000","journal-title":"Annals of Epidemiology"},{"key":"10.1053\/bega.2001.0230_RF59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.46.1.27","article-title":"Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs","volume":"46","author":"Weil","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00001648-199905000-00006","article-title":"Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed","volume":"10","author":"Garcia Rodriguez","year":"1999","journal-title":"Epidemiology"},{"key":"10.1053\/bega.2001.0230_RF61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF62","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF63","first-page":"A2271","article-title":"H. pylori infection increases the risk of non-steroidal anti-inflammatory drug (NSAID)-induced gastroduodenal ulceration","volume":"114","author":"Huang","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0016-5107(97)70114-7","article-title":"Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding","volume":"46","author":"Riemann","year":"1997","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2001.0230_RF65","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1023\/A:1018816729449","article-title":"One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding","volume":"42","author":"Sung","year":"1997","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0230_RF66","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1572-0241.1998.00278.x","article-title":"Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding","volume":"93","author":"Macr\u0131\u0301","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF67","series-title":"Modern Epidemiology","first-page":"311","article-title":"Interactions between causes","author":"Rothman","year":"1986"},{"key":"10.1053\/bega.2001.0230_RF68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.34.6.748","article-title":"Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF69","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1365-2036.2000.00783.x","article-title":"Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis","volume":"14","author":"Leung","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0230_RF70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2036.1999.00550.x","article-title":"Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance","volume":"13","author":"Hawkey","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0230_RF71","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2036.2000.0701a.x","article-title":"On dissonances, Helicobacter pylori and NSAIDs","volume":"14","author":"Calvet","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0230_RF72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/gut.46.3.310","article-title":"Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs","volume":"46","author":"Hawkey","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1023\/A:1018807412030","article-title":"Role of helicobacter pylori infection on upper gastrointestinal bleeding in the elderly\u2013a case\u2013control study","volume":"42","author":"Pilotto","year":"1997","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0230_RF74","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1365-2036.1999.00631.x","article-title":"Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users","volume":"13","author":"Santolaria","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0230_RF75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.41.4.459","article-title":"Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs","volume":"41","author":"Cullen","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0230_RF76","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0016-5085(99)70494-4","article-title":"Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study","volume":"116","author":"Aalykke","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF77","series-title":"Modern Epidemiology","first-page":"51","article-title":"Types of epidemiologic study","author":"Rothman","year":"1986"},{"key":"10.1053\/bega.2001.0230_RF78","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archinte.1987.00370010087021","article-title":"The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding","volume":"147","author":"Carson","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in eldery persons","volume":"114","author":"Griffin","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF81","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0016-5085(93)90952-9","article-title":"Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs","volume":"105","author":"Henry","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0230_RF82","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/S0002-9343(98)00072-2","article-title":"Recent considerations in nonsteroidal anti-inflammatory drug gastropathy","volume":"105","author":"Singh","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF83","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.2001.0230_RF84","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF85","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0230_RF86","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0230_RF87","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF88","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","article-title":"Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0230_RF90","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","article-title":"Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study","volume":"319","author":"De Abajo","year":"1999","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0230_RF91","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199402103300602","article-title":"A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer","volume":"330","author":"Jensen","year":"1994","journal-title":"New England Journal of Medicine"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801902306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801902306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T05:45:33Z","timestamp":1621143933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691801902306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S1521691801902306"],"URL":"https:\/\/doi.org\/10.1053\/bega.2001.0230","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}